GENE ONLINE|News &
Opinion
Blog

2025-11-30|

Wearable Devices Detect Early Physiological Changes Linked to Rheumatoid Arthritis Flares

by GOAI
Share To

Researchers have identified that wearable devices can detect early physiological changes in individuals at risk of rheumatoid arthritis (RA) flares, according to a recent study. The findings suggest that wearable technology may play a role in identifying symptomatic and inflammatory flare-ups before they occur, potentially aiding in the management of this chronic condition.

The study involved collaboration among multiple institutions and explored how digital health tools could monitor subtle physiological shifts linked to RA. Researchers observed that wearables, such as fitness trackers or smartwatches, were able to capture data on metrics like heart rate variability, skin temperature, and physical activity levels. These indicators showed measurable changes prior to the onset of arthritis flares. By analyzing this data, researchers aim to provide patients and healthcare providers with earlier warnings of potential flare-ups, allowing for timely interventions. This research highlights the intersection of medical science and emerging digital health technologies in addressing chronic disease management.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 30, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top